HOME >> BIOLOGY >> NEWS
The amendment to the law on green Genetic Engineering inhibits innovation and research in Germany

This release is also available in German.

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) sees the draft amendment to the Genetic Engineering Act as a restriction on innovation and research in Germany. If the amendment were to be passed in its current form it runs the risk, in the opinion of the DFG, of putting German researchers at a considerable disadvantage on the international playing field. This is the key theme of the statement on the law on genetic engineering recently released by the DFG.

The DFG primarily opposes three aspects of the draft amendment. For instance, the draft put forward by the German federal government assumes that a particular risk is automatically attached to the introduction of genetically modified organisms (GMOs). In the opinion of the DFG this assumption is not backed up by experimental data.

The inappropriate risk assessment leads to increased red tape and hampers the transfer of the findings of basic research to economically viable processes and products. The draft amendment also intends to hold users of genetically modified organisms responsible for "intrusion" by GMOs into conventionally or ecologically produced seed. However, it is not possible in principle to prevent such cross breeding of genetically modified organisms. If the liability proposed in the amendment is enforced, research involving genetically modified organisms or their release will barely be possible in Germany any longer.

Thirdly, the DFG is against the planned splitting of the Central Commission for Biological Safety into two committees and the inclusion of members who do not have relevant technical expertise. The DFG does not perceive a need for new boards, new bureaucratic regulations or additional authorities.

The envisaged establishment of a federal register for recording the location of GMOs and registers for each of the 16 st
'"/>

Contact: Prof. Dr. Jrg Hacker
j.hacker@mail.uni-wuerzburg.de
49-0-9131-31-2575
Deutsche Forschungsgemeinschaft
6-Jul-2004


Page: 1 2

Related biology news :

1. Plants will not save us from greenhouse gases
2. Environmental decontamination, greenhouse gases, and the genome of a methane-loving bacterium
3. Spring through fall, cities are greener longer than neighboring rural regions
4. Urban heat islands make cities greener
5. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
6. New space-borne instrument to track greenhouse gases, ozone destroyers, and other pollutants
7. UK small firms pay lip service to green issues
8. Continents played key role in collapse and regeneration of Earths early greenhouse, geologists say
9. White tea beats green tea in fighting germs
10. Improved crop production and fewer greenhouse gases
11. Emerging frontiers genomics grant for blue-green bacteria

Post Your Comments:
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... July 30, 2015 after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
(Date:7/7/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a biometric ... revised version of one of its first 30 second commercials will ... New York , Chicago , ... metro areas.    , , , , ... the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
(Date:7/29/2015)... Inc. (NYSE: BIOA ) today announced that ... resigned.  The Company has hired Andrew Ashworth , ... 2014, as full time interim CFO and has launched ... Andy Ashworth began his employment today, to overlap ... was the Company,s CFO from September 2011 to December ...
(Date:7/29/2015)... July 29, 2015 ... the addition of the "Global Biosimilars Market, ... The Global Biosimilars Market, 2015 - ... rapidly growing biosimilars market. With the blockbuster biologics ... minimize costs, biosimilars are being viewed as viable ...
(Date:7/29/2015)... 2015  Pfenex Inc. (NYSE MKT: PFNX) announced today ... released on Thursday, August 13, 2015, before the open ... will host a conference call to discuss the financial ... outlining the financial results and business update will be ... call 1-866-376-8058 (US) or 1-412-542-4131 (international) and reference Pfenex ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: